Atlas Trials

Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

Clinical trial NCT04784754 · WITHDRAWN

Trial details

NCT number
NCT04784754
Sponsor
State University of New York at Buffalo
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-04-01
Primary completion
2022-09-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.